ST. LOUIS--(BUSINESS WIRE)--Geneoscopy announced that Exact Sciences has withdrawn its motion for a preliminary injunction regarding the '781 patent and the ā746 patent.
Related Questions
How will the withdrawal of the preliminary injunction affect Geneoscopy's shortāterm stock momentum?
What potential market share gains could Geneoscopy achieve if the 781 and 746 patents are upheld?
Could this legal outcome trigger any strategic moves or partnerships within the colorectal diagnostics sector?